Pancreas-Targeted GLP-1Gene Therapy Enhances β-Cell Function and Reduces Cellular Stress in Preclinical Type 2 Diabetes Models

Fractyl Health Inc. published this content on June 10, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 10, 2026 at 18:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]